Cytocom therapeutics
WebImmune Therapeutics, Inc. (“the Company”, “Immune”) was initially incorporated in Florida on December 2, 1993, as Resort Clubs International, Inc. (“Resort Clubs”). It was formed to manage and market golf course properties in resort markets throughout the United States. ... In December 2013, the Company formed a subsidiary, Cytocom ... WebJul 28, 2024 · Cytocom, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases and cancers based on a proprietary platform...
Cytocom therapeutics
Did you know?
WebAug 20, 2024 · Cytocom has agreed to reacquire the emerging market rights for its late-stage drug candidates CYTO-201 and CYTO-401 from Immune Therapeutics in … WebApr 27, 2024 · Statera Biopharma (formerly Cytocom, Inc.) is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers...
WebSep 28, 2024 · Cytocom is developing therapies designed to elicit directly within patients a robust and durable response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. WebMar 6, 2024 · Using opioid treatments to manage immunity Cytocom’s main drug of focus is naltrexone, which is currently approved for use in treating alcoholism and opioid addiction. It’s a similar compound to...
WebApr 12, 2024 · Cytocom Inc Registered Shs - - USD *Yield of the Respective Date. Cytocom Profile . Statera Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel ... WebOct 20, 2024 · Cytocom, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases and cancers based on a proprietary platform designed to rebalance the body’s immune system and restore homeostasis.
WebJan 11, 2024 · For more information on Cytocom and their participation in these please go to their website at www.Cytocom.com. Immune Therapeutics: (888) 613-8802 www.immunetherapeutics.com . GlobeNewswire. January 11, 2024 - 7:31 AM PST. Tags: BIOTECHNOLOGY HEALTHCARE. Related News
WebMar 20, 2024 · Immune Therapeutics and Cytocom are planning to work with federal agencies to seek fast-track approval using Lodonal™ as a way to prevent or treat COVID … hideaway anchorageWebCYTO-200 program therapies, are noroxymorphone analogs developed by discovering the anti-angiogenic and anti-inflammatory properties of naltrexone, yielding a new way of fighting cancer, inflammatory, … howell territorial park sauvie islandWebImmune Therapeutics and Cytocom are planning to work with federal agencies to seek fast-track approval using Lodonal™ as a way to prevent or treat COVID-19 in high-risk groups who are infected with 2024-nCoV at clinical research centers across the country. IMUN is currently designing studies using Lodonal™ and IRT-101 as a monotherapy or in ... howell testimonyWebMar 29, 2024 · About CytomX Therapeutics, Inc. 151 OYSTER POINT BOULEVARD SUITE 400, SOUTH SAN FRANCISCO, California, 94080, United States +1 650 515 … hideaway anstrutherWebStatera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, … hideaway andersonWebJul 6, 2024 · Cytocom, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases and cancers based on a proprietary platform... howell thaiWebCytocom, Inc. – novel immunotherapies targeting autoimmune diseases, infectious diseases, inflammatory diseases, and cancers CYTO-400 Proenkephalin Platform CYTO … Cytocom, Inc. is a clinical-stage biopharmaceutical company developing … CYTO-601 ARS: Cytocom is hopeful that the CYTO-600 efficacy, safety and … Cytocom, Inc. Cutting edge developer of a new class of Immunotherapies targeting … Incuron, LLC. is a royalty partner with Cytocom focused on the development of … Cytocom, Inc. Cutting edge developer of a new class of Immunotherapies targeting … The transfer Agent and registrar for the common stock of Cytocom stock is: … Continental Stock Transfer & Trust Company 1 State Street Plaza 30th … howell texas map